$FOR
Forestar Group Inc.

2021 Q1 Form 10-Q Financial Statement

#000140658721000050 Filed on April 23, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $287.1M $159.1M
YoY Change 80.45% 143.64%
Cost Of Revenue $233.8M $136.6M
YoY Change 71.16% 213.3%
Gross Profit $53.30M $22.50M
YoY Change 136.89% 3.69%
Gross Profit Margin 18.56% 14.14%
Selling, General & Admin $16.30M $11.20M
YoY Change 45.54% 80.65%
% of Gross Profit 30.58% 49.78%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $700.0K $1.500M
YoY Change -53.33% -6.25%
% of Gross Profit 1.31% 6.67%
Operating Expenses $16.30M $11.20M
YoY Change 45.54% 80.65%
Operating Profit $37.00M $11.30M
YoY Change 227.43% -27.1%
Interest Expense $600.0K $2.100M
YoY Change -71.43%
% of Operating Profit 1.62% 18.58%
Other Income/Expense, Net
YoY Change
Pretax Income $37.60M $13.70M
YoY Change 174.45% -16.46%
Income Tax $9.200M $3.300M
% Of Pretax Income 24.47% 24.09%
Net Earnings $28.40M $9.600M
YoY Change 195.83% -4.95%
Net Earnings / Revenue 9.89% 6.03%
Basic Earnings Per Share $0.59 $0.20
Diluted Earnings Per Share $0.59 $0.20
COMMON SHARES
Basic Shares Outstanding 48.41M shares 48.03M shares
Diluted Shares Outstanding 48.51M shares 48.08M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $167.2M $438.2M
YoY Change -61.84% 559.94%
Cash & Equivalents $167.2M $438.2M
Short-Term Investments
Other Short-Term Assets $5.300M $4.400M
YoY Change 20.45% 33.33%
Inventory
Prepaid Expenses
Receivables $3.200M $1.000M
Other Receivables $0.00 $0.00
Total Short-Term Assets $175.7M $443.6M
YoY Change -60.39% 523.91%
LONG-TERM ASSETS
Property, Plant & Equipment $2.000M $1.000M
YoY Change 100.0% -58.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $900.0K $5.700M
YoY Change -84.21% -22.97%
Other Assets $8.000M
YoY Change -79.27%
Total Long-Term Assets $1.723B $1.232B
YoY Change 39.87% 34.82%
TOTAL ASSETS
Total Short-Term Assets $175.7M $443.6M
Total Long-Term Assets $1.723B $1.232B
Total Assets $1.899B $1.676B
YoY Change 13.33% 70.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $39.80M $23.10M
YoY Change 72.29% 59.31%
Accrued Expenses $98.90M $59.00M
YoY Change 67.63% 78.79%
Deferred Revenue $200.0K $3.100M
YoY Change -93.55%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $281.7M $182.7M
YoY Change 54.19% 44.54%
LONG-TERM LIABILITIES
Long-Term Debt $654.6M $640.1M
YoY Change 2.27% 329.02%
Other Long-Term Liabilities $10.70M $6.600M
YoY Change 62.12% -38.32%
Total Long-Term Liabilities $665.3M $646.7M
YoY Change 2.88% 304.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $281.7M $182.7M
Total Long-Term Liabilities $665.3M $646.7M
Total Liabilities $954.4M $838.8M
YoY Change 13.78% 182.33%
SHAREHOLDERS EQUITY
Retained Earnings $269.3M $184.6M
YoY Change 45.88% 33.29%
Common Stock $674.4M $651.3M
YoY Change 3.55% 18.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $943.7M $835.9M
YoY Change
Total Liabilities & Shareholders Equity $1.899B $1.676B
YoY Change 13.33% 70.13%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $28.40M $9.600M
YoY Change 195.83% -4.95%
Depreciation, Depletion And Amortization $700.0K $1.500M
YoY Change -53.33% -6.25%
Cash From Operating Activities -$90.80M -$112.2M
YoY Change -19.07% -6.03%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K -$200.0K
YoY Change -50.0% -71.43%
Acquisitions
YoY Change
Other Investing Activities $100.0K $600.0K
YoY Change -83.33%
Cash From Investing Activities $0.00 $400.0K
YoY Change -100.0% -157.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.60M 176.7M
YoY Change -88.34% 453.92%
NET CHANGE
Cash From Operating Activities -90.80M -112.2M
Cash From Investing Activities 0.000 400.0K
Cash From Financing Activities 20.60M 176.7M
Net Change In Cash -70.20M 64.90M
YoY Change -208.17% -173.58%
FREE CASH FLOW
Cash From Operating Activities -$90.80M -$112.2M
Capital Expenditures -$100.0K -$200.0K
Free Cash Flow -$90.70M -$112.0M
YoY Change -19.02% -5.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001406587
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33662
dei Entity Registrant Name
EntityRegistrantName
FORESTAR GROUP INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1336998
dei Entity Address Address Line1
EntityAddressAddressLine1
2221 E. Lamar Blvd., Suite 790
dei Entity Address City Or Town
EntityAddressCityOrTown
Arlington
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
76006
dei City Area Code
CityAreaCode
817
dei Local Phone Number
LocalPhoneNumber
769-1860
dei Security12b Title
Security12bTitle
Common Stock, par value $1.00 per share
dei Trading Symbol
TradingSymbol
FOR
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49124801 shares
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
167200000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
394300000 USD
CY2021Q1 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1698600000 USD
CY2020Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1309700000 USD
CY2021Q1 us-gaap Equity Method Investments
EquityMethodInvestments
900000 USD
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
3600000 USD
CY2021Q1 us-gaap Income Tax Receivable
IncomeTaxReceivable
0 USD
CY2020Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
6300000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2000000.0 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1100000 USD
CY2021Q1 us-gaap Other Assets
OtherAssets
30200000 USD
CY2020Q3 us-gaap Other Assets
OtherAssets
24900000 USD
CY2021Q1 us-gaap Assets
Assets
1898900000 USD
CY2020Q3 us-gaap Assets
Assets
1739900000 USD
CY2021Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
39800000 USD
CY2020Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
29200000 USD
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
140200000 USD
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
98300000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7400000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
5700000 USD
CY2021Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
112400000 USD
CY2020Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
93800000 USD
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
654600000 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
641100000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
954400000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
868100000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48400000 shares
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49124801 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48061921 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
49100000 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
48100000 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
625300000 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
603900000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
269300000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
218900000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
943700000 USD
us-gaap Net Income Loss
NetIncomeLoss
26400000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
870900000 USD
CY2021Q1 us-gaap Minority Interest
MinorityInterest
800000 USD
CY2020Q3 us-gaap Minority Interest
MinorityInterest
900000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
944500000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
871800000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1898900000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1739900000 USD
CY2021Q1 us-gaap Revenues
Revenues
287100000 USD
CY2020Q1 us-gaap Revenues
Revenues
159100000 USD
us-gaap Revenues
Revenues
594200000 USD
us-gaap Revenues
Revenues
406400000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
233800000 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
136600000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
496700000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
353200000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16300000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11200000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
31800000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21700000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
100000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
300000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
300000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
800000 USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2020Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
300000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
100000 USD
CY2021Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
500000 USD
CY2020Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1800000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
800000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
3400000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
37600000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13700000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
66800000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35800000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9200000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3300000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16300000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8700000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
28400000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
10400000 USD
us-gaap Profit Loss
ProfitLoss
50500000 USD
us-gaap Profit Loss
ProfitLoss
27100000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
800000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
100000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
700000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
28400000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
9600000 USD
us-gaap Net Income Loss
NetIncomeLoss
50400000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48000000.0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48300000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48000000.0 shares
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48500000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48100000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48400000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48100000 shares
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
871800000 USD
CY2020Q4 us-gaap Profit Loss
ProfitLoss
22100000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2020Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
100000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
300000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
894100000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
28400000 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
23300000 USD
CY2021Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
-1900000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
300000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
900000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
944500000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
808900000 USD
CY2019Q4 us-gaap Profit Loss
ProfitLoss
16800000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2019Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
200000 USD
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
500000 USD
CY2019Q4 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
400000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
825600000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
10400000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
800000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
836800000 USD
us-gaap Profit Loss
ProfitLoss
50500000 USD
us-gaap Profit Loss
ProfitLoss
27100000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1500000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3400000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
2200000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
9400000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
300000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
800000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1200000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1300000 USD
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
900000 USD
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
400000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
100000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
377300000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
170700000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-6300000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-700000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6500000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4500000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
29200000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1000000.0 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
42800000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
11000000.0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-249500000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-123800000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
200000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
200000 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
2200000 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
2400000 USD
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
0 USD
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
1300000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2000000.0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3500000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
300000000.0 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
118900000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
4800000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
23300000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-2400000 USD
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
0 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
100000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
400000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
400000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
200000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20400000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
175700000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-227100000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
55400000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
394300000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
382800000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
167200000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
438200000 USD
us-gaap Notes Issued1
NotesIssued1
12500000 USD
us-gaap Notes Issued1
NotesIssued1
0 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</span></div>
CY2021Q1 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
55500000 USD
CY2020Q3 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
5400000 USD
CY2021Q1 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1698600000 USD
CY2020Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1309700000 USD
us-gaap Payments To Acquire Residential Real Estate
PaymentsToAcquireResidentialRealEstate
484600000 USD
us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
369400000 USD
CY2021Q1 for Due Diligence Write Offs
DueDiligenceWriteOffs
600000 USD
for Due Diligence Write Offs
DueDiligenceWriteOffs
900000 USD
CY2020Q1 for Due Diligence Write Offs
DueDiligenceWriteOffs
100000 USD
for Due Diligence Write Offs
DueDiligenceWriteOffs
400000 USD
CY2021Q1 us-gaap Revenues
Revenues
287100000 USD
CY2020Q1 us-gaap Revenues
Revenues
159100000 USD
us-gaap Revenues
Revenues
594200000 USD
us-gaap Revenues
Revenues
406400000 USD
CY2020Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
51000000.0 USD
CY2019Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
29800000 USD
CY2020Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
48700000 USD
CY2019Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
23700000 USD
CY2021Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
11500000 USD
CY2020Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
10600000 USD
us-gaap Interest Costs Incurred
InterestCostsIncurred
23000000.0 USD
us-gaap Interest Costs Incurred
InterestCostsIncurred
20500000 USD
CY2021Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
8200000 USD
CY2020Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
2500000 USD
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
17400000 USD
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
6300000 USD
CY2021Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
54300000 USD
CY2020Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
37900000 USD
CY2021Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
54300000 USD
CY2020Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
37900000 USD
CY2021Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
3200000 USD
CY2020Q3 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
400000 USD
CY2021Q1 us-gaap Notes Receivable Related Parties
NotesReceivableRelatedParties
2600000 USD
CY2020Q3 us-gaap Notes Receivable Related Parties
NotesReceivableRelatedParties
4800000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4900000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3600000 USD
CY2021Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
5300000 USD
CY2020Q3 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
4900000 USD
CY2021Q1 us-gaap Deposits Assets
DepositsAssets
9900000 USD
CY2020Q3 us-gaap Deposits Assets
DepositsAssets
5500000 USD
CY2021Q1 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
4300000 USD
CY2020Q3 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
5700000 USD
CY2021Q1 us-gaap Other Assets
OtherAssets
30200000 USD
CY2020Q3 us-gaap Other Assets
OtherAssets
24900000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
5900000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
6200000 USD
CY2021Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
1800000 USD
CY2020Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
3800000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
5300000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3800000 USD
CY2021Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
14300000 USD
CY2020Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
14000000.0 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
200000 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
200000 USD
CY2021Q1 us-gaap Deferred Revenue
DeferredRevenue
9300000 USD
CY2020Q3 us-gaap Deferred Revenue
DeferredRevenue
9300000 USD
CY2021Q1 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
2800000 USD
CY2020Q3 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
500000 USD
CY2021Q1 for Accrued Development Costs
AccruedDevelopmentCosts
68200000 USD
CY2020Q3 for Accrued Development Costs
AccruedDevelopmentCosts
44400000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
3400000 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
10200000 USD
CY2021Q1 us-gaap Other Liabilities
OtherLiabilities
1200000 USD
CY2020Q3 us-gaap Other Liabilities
OtherLiabilities
1400000 USD
CY2021Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
112400000 USD
CY2020Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
93800000 USD
CY2021Q1 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2020Q3 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
654600000 USD
CY2021Q1 for Letterof Credit Maximum Borrowing Capacity Percentageof Revolving Credit Commitment
LetterofCreditMaximumBorrowingCapacityPercentageofRevolvingCreditCommitment
0.50
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
641100000 USD
CY2021Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
380000000 USD
CY2021Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
570000000 USD
CY2021Q1 for Letterof Credit Maximum Borrowing Capacity
LetterofCreditMaximumBorrowingCapacity
100000000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 USD
CY2021Q1 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2021Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
46000000.0 USD
CY2021Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
334000000.0 USD
CY2020Q2 for Debt Repurchase Program Authorized Amount
DebtRepurchaseProgramAuthorizedAmount
30000000 USD
CY2021Q1 for Debt Repurchase Program Authorized Amount
DebtRepurchaseProgramAuthorizedAmount
30000000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
28400000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
9600000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
50400000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
26400000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48412213 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48025359 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48270718 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48018246 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
97711 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
57592 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
80692 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
56439 shares
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3300000 USD
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48509924 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48082951 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48351410 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48074685 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16300000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8700000 USD
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.245
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.244
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.241
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
CY2021Q1 for Deferred Income Tax Liabilities Net Of Deferred Income Tax Assets
DeferredIncomeTaxLiabilitiesNetOfDeferredIncomeTaxAssets
-6100000 USD
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1300000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7400000 USD
CY2020Q3 for Deferred Income Tax Liabilities Net Of Deferred Income Tax Assets
DeferredIncomeTaxLiabilitiesNetOfDeferredIncomeTaxAssets
-4200000 USD
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1500000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
5700000 USD
CY2018Q3 for Equity Securities Registered Value
EquitySecuritiesRegisteredValue
500000000 USD
CY2020Q3 for At The Market Equity Offering Program Common Stock Available For Issuance
AtTheMarketEquityOfferingProgramCommonStockAvailableForIssuance
100000000 USD
CY2021Q1 for At The Market Equity Offering Program Common Stock Issued
AtTheMarketEquityOfferingProgramCommonStockIssued
1000000.0 shares
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
23300000 USD
CY2021Q1 for Common Stock Availablefor Issuance Value Remaining
CommonStockAvailableforIssuanceValueRemaining
370600000 USD
CY2021Q1 for At The Market Equity Offering Program Common Stock Available For Issuance
AtTheMarketEquityOfferingProgramCommonStockAvailableForIssuance
76300000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
232320 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
23.12
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
900000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1200000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
800000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1300000 USD
CY2021Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
46000000.0 USD
CY2021Q1 us-gaap Special Assessment Bond
SpecialAssessmentBond
368600000 USD
CY2021Q1 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
84500 Lot
CY2020Q3 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
60500 Lot
CY2021Q1 for Numberof Lots Sold
NumberofLotsSold
3588 Lot
CY2020Q1 for Numberof Lots Sold
NumberofLotsSold
1951 Lot
for Numberof Lots Sold
NumberofLotsSold
7155 Lot
for Numberof Lots Sold
NumberofLotsSold
4373 Lot
CY2021Q1 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
55500000 USD
CY2020Q3 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
5400000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
167200000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
394300000 USD

Files In Submission

Name View Source Status
0001406587-21-000050-index-headers.html Edgar Link pending
0001406587-21-000050-index.html Edgar Link pending
0001406587-21-000050.txt Edgar Link pending
0001406587-21-000050-xbrl.zip Edgar Link pending
a3312021exhibit311.htm Edgar Link pending
a3312021exhibit312.htm Edgar Link pending
a3312021exhibit321.htm Edgar Link pending
a3312021exhibit322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
for-20210331.htm Edgar Link pending
for-20210331.xsd Edgar Link pending
for-20210331_cal.xml Edgar Link unprocessable
for-20210331_def.xml Edgar Link unprocessable
for-20210331_htm.xml Edgar Link completed
for-20210331_lab.xml Edgar Link unprocessable
for-20210331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending